Sorafenib for patients with differentiated thyroid cancer--authors' reply

Affiliations

¹ Department of Otorhinolaryngology: Head and Neck Surgery, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: brosem@mail.med.upenn.edu.
² Gustave Roussy, Villejuif, France.
³ Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.
⁴ Bayer Pharma AG, Berlin, Germany.

Comment

Marcia S Brose et al. Lancet. 2015.

. 2015 Jan 17;385(9964):228-9.

doi: 10.1016/S0140-6736(15)60056-3.

¹ Department of Otorhinolaryngology: Head and Neck Surgery, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: brosem@mail.med.upenn.edu.
² Gustave Roussy, Villejuif, France.
³ Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.
⁴ Bayer Pharma AG, Berlin, Germany.

No abstract available

Comment on

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ; DECISION investigators. Brose MS, et al. Lancet. 2014 Jul 26;384(9940):319-28. doi: 10.1016/S0140-6736(14)60421-9. Epub 2014 Apr 24. Lancet. 2014. PMID: 24768112 Free PMC article. Clinical Trial.
Sorafenib for patients with differentiated thyroid cancer.
Boudou-Rouquette P, Thomas-Schoemann A, Bellesoeur A, Goldwasser F. Boudou-Rouquette P, et al. Lancet. 2015 Jan 17;385(9964):227-8. doi: 10.1016/S0140-6736(15)60054-X. Lancet. 2015. PMID: 25706704 No abstract available.
Sorafenib for patients with differentiated thyroid cancer.
Huillard O, Blanchet B, Durand JP, Goldwasser F. Huillard O, et al. Lancet. 2015 Jan 17;385(9964):227. doi: 10.1016/S0140-6736(15)60053-8. Lancet. 2015. PMID: 25706705 No abstract available.
Sorafenib for patients with differentiated thyroid cancer.
Lee HJ, Ryu H, Choi YS, Song IC, Yun HJ, Jo DY, Kim S. Lee HJ, et al. Lancet. 2015 Jan 17;385(9964):228. doi: 10.1016/S0140-6736(15)60055-1. Lancet. 2015. PMID: 25706707 No abstract available.